Susquehanna International Group
MYOK

Susquehanna International Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Susquehanna International Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-62,400
Closed -$8.51M – 12072
2020
Q3 		$8.51M Sell
62,400
-23,000
-27% -$2.45M ﹤0.01% 2376
2020
Q2 		$8.25M Sell
85,400
-125,800
-60% -$10.5M ﹤0.01% 2367
2020
Q1 		$9.9M Buy
211,200
+160,500
+317% +$10.3M ﹤0.01% 1751
2019
Q4 		$3.69M Sell
50,700
-19,300
-28% -$1.17M ﹤0.01% 3396
2019
Q3 		$3.65M Buy
70,000
+14,000
+25% +$744K ﹤0.01% 3185
2019
Q2 		$2.81M Sell
56,000
-21,500
-28% -$1.05M ﹤0.01% 3551
2019
Q1 		$4.03M Buy
77,500
+36,000
+87% +$1.66M ﹤0.01% 2714
2018
Q4 		$2.03M Buy
41,500
+9,200
+28% +$506K ﹤0.01% 3499
2018
Q3 		$2.11M Sell
32,300
-14,700
-31% -$864K ﹤0.01% 3897
2018
Q2 		$2.33M Sell
47,000
-65,400
-58% -$3.17M ﹤0.01% 3757
2018
Q1 		$5.49M Buy
112,400
+97,300
+644% +$5.06M ﹤0.01% 2431
2017
Q4 		$636K Buy
+15,100
New +$582K ﹤0.01% 6157

Susquehanna International Group's MYOK Position: Q4 2020 in Review

Susquehanna International Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.

Susquehanna International Group first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Susquehanna International Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
  • Susquehanna International Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
  • Susquehanna International Group's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.